Sponsored by Merck 23 Jun 2022 How a global network accelerated the development of a virus-like particle vaccine against Covid-19 Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines in Europe and North America are regarded as part of the general medical plan, vaccine supply has always been a pressing issue in African countries. In the current Covid-19 pandemic, the ability to develop and manufacture vaccines in Africa instead […] June 23, 2022 - 5 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Sponsored by Biovian 7 Jun 2022 Gene therapy: can CDMOs solve the manufacturing bottleneck? The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for viral vectors and their plasmid building blocks have resulted in a manufacturing bottleneck. Can contract manufacturing organizations cope with the rising demand? In 2019, Zolgensma, a […] June 7, 2022 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Sponsored by Merck 26 Jan 2022 Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in process development, optimization, and scale-up. In this article, we share an exclusive sneak-peek into a recent survey, which explores the main reasons why biotech companies collaborate with CDMOs at different stages of drug development. To make a new drug candidate […] January 26, 2022 - 8 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Sponsored by Cytiva 18 Jan 2022 How to Make Cell Culture Expansion Easy Cell culture expansion for biotherapeutic development has traditionally involved a series of time-consuming, labor-intensive batch cultures that are susceptible to contamination. Cell culture expansion using a perfusion process promises easy scalability, ensures high productivity gains, and saves time and costs during large-scale biomanufacturing. Cell culture is a crucial tool in the biotech sector. Applications range […] January 18, 2022 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Infographics by Merck 15 Nov 2021 Gene therapy: Making Rare Disease Therapies Less Rare While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide. Many rare conditions are chronic, progressive, and life-threatening with limited treatment options available. Advances in gene therapy provide hope to actual cures and could revolutionize treatment prospects for patients with rare genetic diseases. This infographic shows how we can unlock […] November 15, 2021 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by OXGENE 26 Oct 2021 Plasmids: How to Solve a Bottleneck in Scalable Gene Therapy Manufacturing? As gene therapies become increasingly successful, companies are in a competitive race to deliver manufacturing technologies that can streamline large-scale production at reduced costs and faster turnaround times. However, plasmids, the building blocks of viral vectors, remain a bottleneck in gene therapy manufacturing. Two companies have united to provide exciting alternatives. With over 2,400 gene […] October 26, 2021 - 7 minutesmins - By Letícia Manosso Share WhatsApp Twitter Linkedin Email
Sponsored by Charles River 28 Sep 2021 Artificial Intelligence: A Road to Faster and Better Drug Discovery? Artificial intelligence (AI) has become a part of everyday modern life and continues to generate excitement. In this article, we will take a look at how biotechs are advancing into AI-facilitated early drug design, its real-world outcomes so far, and whether it is living up to its potential in the life science industry. AI enables […] September 28, 2021 - 6 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by WuXi AppTec 22 Sep 2021 Discovering New Therapeutic Targets for Alzheimer’s Disease Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Strategic partnerships can help biotech companies manage costs and access the latest technologies to drive innovation and advance novel therapy ideas. A serious unmet medical need Finding treatments for neurodegenerative […] September 22, 2021 - 7 minutesmins - By Julia Kaiser Share WhatsApp Twitter Linkedin Email
Sponsored by Eppendorf 26 Aug 2021 Stem Cell-based Cultured Meat: No Longer Science Fiction Since the turn of the century, stem cell technology has delivered on its promise to transform the healthcare industry, while its applications across different sectors have continued to emerge. Bioreactors, offering improved process control as well as scalability, have been adopted worldwide for stem cell production and cultivation. Join us as we dive into the […] August 26, 2021 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Sponsored by Merck 2 Mar 2021 How is Bioprocessing 4.0 Revolutionizing Biomanufacturing? The digital transformation of biopharmaceutical process development is known as Bioprocessing 4.0. Using the internet of things, digital biomanufacturing creates a network of data sources, materials, equipment, and industry representatives. This creates a competitive advantage, increases productivity, and boosts the value of biomanufacturing. We have spoken to Merrilee Whitney, Head of the BioContinuum™ platform at Merck* […] March 2, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by PCMG 8 Jun 2020 Why Biotechs Should Invest in Good Outsourcing Management of CROs The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs is seen as a standard in the drug development industry. However, the management of drug development partners and providers can be highly challenging for biotechs. This is where outsourcing expertise can make the difference between […] June 8, 2020 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored 27 Nov 2019 How to Address the Challenges of Biologics Discovery and Development The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […] November 27, 2019 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email